Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/2366| Title: | "Comparative Analysis of Ceftazidime-Avibactam Brands: Evaluating Price, Potency, and Cost-Effectiveness for Enhanced Patient Outcomes and Affordability" and "Assessing the Healthcare Cost Implications of Drug Price Control Organization's (DPCO) Decision: A Case Study on Meropenem Price Ceiling “ |
| Authors: | Ahuja, Suraj |
| Keywords: | Pharmaceutical Case Study Drug Price Control Organization's Healthcare Cost-Effectiveness Healthcare Cost Implications |
| Issue Date: | 2023 |
| Publisher: | IIHMR University |
| URI: | http://localhost:8080/xmlui/handle/123456789/2366 |
| Appears in Collections: | 2023 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Suraj-c.pdf | Certificate | 521.47 kB | Adobe PDF | Preview PDFDownload |
| Suraj-p.pdf | Presentation | 2.09 MB | Adobe PDF | Preview PDFDownload |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.